Literature DB >> 977734

Evaluation of commercial Salmonella O polyvalent and Vi antisera.

G M Evins, L L Linne, H M Colvin.   

Abstract

Salmonella somatic polyvalent antisera for groups A through E or A through I with or without Vi and Salmonella Vi antisera were purchased from four commercial producers and evaluated. Center for Disease Control (CDC) methods and specifications were used. The four polyvalent and two of the four Vi antisera did not meet CDC performance specifications. Suggestions are made for improving the laboratory usefulness of the reagents and the product labeling.

Mesh:

Substances:

Year:  1976        PMID: 977734      PMCID: PMC274471          DOI: 10.1128/jcm.4.4.349-353.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  1 in total

1.  [Study on the antigenic relationships between the group O:54 and other groups O of Salmonella].

Authors:  L Le Minor; R Rohde; C Charié-Marsaines; C Coynault
Journal:  Ann Inst Pasteur (Paris)       Date:  1971-10
  1 in total
  2 in total

1.  Assessment of availability and efficacy of commercial Salmonella grouping antisera.

Authors:  G M Evins; L L Linne; H M Colvin
Journal:  J Clin Microbiol       Date:  1978-10       Impact factor: 5.948

2.  Characterization of a monoclonal antibody directed against Salmonella enterica serovar Typhimurium and serovar [4,5,12:i:-].

Authors:  A Rementeria; A B Vivanco; A Ramirez; F L Hernando; J Bikandi; S Herrera-León; A Echeita; J Garaizar
Journal:  Appl Environ Microbiol       Date:  2009-01-05       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.